A detailed history of Pictet Asset Management Holding Sa transactions in Nuvalent, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 621,133 shares of NUVL stock, worth $52.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
621,133
Previous 568,884 9.18%
Holding current value
$52.1 Million
Previous $43.2 Million 47.24%
% of portfolio
0.07%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$67.44 - $112.17 $3.52 Million - $5.86 Million
52,249 Added 9.18%
621,133 $63.5 Million
Q2 2024

Aug 13, 2024

BUY
$62.76 - $81.61 $23 Million - $29.9 Million
366,528 Added 181.13%
568,884 $43.2 Million
Q1 2024

May 14, 2024

BUY
$72.35 - $88.99 $604,267 - $743,244
8,352 Added 4.31%
202,356 $15.2 Million
Q4 2023

Feb 13, 2024

BUY
$42.42 - $80.28 $8.23 Million - $15.6 Million
194,004 New
194,004 $14.3 Million

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.6B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.